fashion -WSS

fashion

author：fashion 2025-09-30 09:30:29 - browse：8833

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： STAT letters to the editor on burnt

focus

leisure time

WSS

Medical experts exlpore how to eliminate bias in clinical algorithms

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Eating disorder hotline's move to chatbot carried cost for volunteers

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Wikipedia

fashion

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

DIEP, the 'gold standard' of breast reconstruction, is under threat

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Tori Bowie and the unacceptable rates of Black maternal death

GOP inquiry over gain

The cancer drug shortage isn’t new — and neither are the solutions

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Sports medicine is finally prioritizing gender equality

Supreme Court rules employers must be more accommodating of religious observance

Wikipedia

What PEPFAR has meant on the ground in Ukraine

Pregnancy discrimination could be enabled by AI

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Thousands protest in Iraq for a second day over burning of Quran in Sweden

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Americans' trust in science, scientist continues decline: Report

focus

Wikipedia

leisure time

focus